Zsombor Ritter
Overview
Explore the profile of Zsombor Ritter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
16
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Krajnc D, Spielvogel C, Ecsedi B, Ritter Z, Alizadeh H, Hacker M, et al.
Eur J Nucl Med Mol Imaging
. 2025 Mar;
PMID: 40053121
Background: Artificial Intelligence (AI) approaches in clinical science require extensive data preprocessing (DP) steps prior to building AI models. Establishing DP pipelines is a non-trivial task, mainly driven by purely...
2.
Sipos D, Debreczeni-Mate Z, Ritter Z, Freihat O, Simon M, Kovacs A
Pharmaceuticals (Basel)
. 2024 Sep;
17(9).
PMID: 39338377
Glioblastoma multiforme (GBM) remains one of the most aggressive and lethal forms of brain cancer, characterized by rapid proliferation and diffuse infiltration into the surrounding brain tissues. Despite advancements in...
3.
Baliko A, Szakacs Z, Kajtar B, Ritter Z, Gyenesei A, Farkas N, et al.
Front Oncol
. 2023 Sep;
13:1224733.
PMID: 37746254
Background: The clinical and genetic heterogeneity of diffuse large B-cell lymphoma (DLBCL) presents distinct challenges in predicting response to therapy and overall prognosis. The main objective of this study was...
4.
Krajnc D, Spielvogel C, Grahovac M, Ecsedi B, Rasul S, Poetsch N, et al.
Front Oncol
. 2022 Oct;
12:1017911.
PMID: 36303841
Background: This study proposes machine learning-driven data preparation (MLDP) for optimal data preparation (DP) prior to building prediction models for cancer cohorts. Methods: A collection of well-established DP methods were...
5.
Szakacs Z, Lal A, Kristensen J, Farkas N, Ritter Z, Kiss S, et al.
Adv Radiat Oncol
. 2022 Sep;
7(5):100882.
PMID: 36148378
Purpose: B-cell non-Hodgkin lymphomas (NHLs) are significant contributors to cancer-related mortality. In this single-arm, retrospective cohort study, we aimed to examine the outcomes of a radioimmunotherapeutic modality, Y-labeled ibritumomab tiuxetan...
6.
Two-Year Event-Free Survival Prediction in DLBCL Patients Based on Radiomics and Clinical Parameters
Ritter Z, Papp L, Zambo K, Toth Z, Dezso D, Veres D, et al.
Front Oncol
. 2022 Jun;
12:820136.
PMID: 35756658
Purpose: For the identification of high-risk patients in diffuse large B-cell lymphoma (DLBCL), we investigated the prognostic significance of radiomics derived from baseline [F]FDG PET/CT and clinical parameters. Methods: Pre-treatment...
7.
Szabo L, Molnar R, Tomesz A, Deutsch A, Darago R, Varjas T, et al.
Nutrients
. 2022 Feb;
14(4).
PMID: 35215560
DNA methylation is an epigenetic mechanism that is crucial for mammalian development and genomic stability. Aberrant DNA methylation changes have been detected not only in malignant tumor tissues; the decrease...
8.
Ritter Z, Zambo K, Balogh P, Szollosi D, Jia X, Balazs A, et al.
Sci Rep
. 2021 Dec;
11(1):24002.
PMID: 34907289
Cerenkov luminescence imaging (CLI) is a promising approach to image-guided surgery and pathological sampling. It could offer additional advantages when combined to whole-body isotope tomographies. We aimed to obtain evidence...
9.
Ritter Z, Zambo K, Jia X, Szollosi D, Dezso D, Alizadeh H, et al.
Int J Mol Sci
. 2021 Apr;
22(9).
PMID: 33922728
Bc-DLFL.1 is a novel spontaneous, high-grade transplantable mouse B-cell lymphoma model for selective serosal propagation. These cells attach to the omentum and mesentery and show dissemination in mesenteric lymph nodes....